Xero’s share price (ASX:XRO) has been under pressure recently, today closing at A$76.92, marking a new three-year low as the company’s ambitious U.S. expansion strategy collides with deteriorating market sentiment and margin pressures that have wiped more than A$17 billion from its market capitalisation.
Xero shares declined 8.43% in today’s session to close at A$76.92, extending the year-to-date loss to 31.47% and marking a precipitous 60% decline from the stock’s June 2025 highs.
The relentless selling pressure has seen the company’s market value contract from more than A$28 billion at its peak to roughly A$11 billion currently, with no meaningful support emerging at key technical levels. The stock has breached multiple psychological thresholds in recent months, including the A$100 mark last month, as markets reassess the company’s valuation amid strategic uncertainty and execution risks.
Why The Selling Pressure?
The sharp reversal in Xero’s fortunes can in part be traced to June 2025, when the company announced its acquisition of U.S.-based payments platform Melio for US$2.5 billion. To finance the transaction, Xero conducted a fully underwritten institutional placement, raising A$1.85 billion through the issuance of approximately 10.5 million shares at A$176 each, representing a 9.4% discount to the prevailing market price. Markets reacted negatively to the announcement, with shares dropping 9% upon resumption of trading as concerns mounted over the substantial capital commitment and dilution to existing shareholders.
The company’s November 2025 half-year financial results, while showing top-line growth, failed to reassure markets about profitability trajectory. Xero reported operating revenue of NZ$1.19 billion, up 20% year-on-year, and EBITDA of NZ$378 million, representing a 21% increase. However, the share price fell approximately 5% following the announcement as markets focused on declining gross profit margins and potential integration challenges associated with the Melio acquisition. The results highlighted the tension between Xero’s growth ambitions and its ability to maintain operational efficiency during a period of significant strategic transformation.
Top Australian Brokers
- Pepperstone - Top Australian broker - Read our review
- eToro - Invest in ASX and international shares - Read our review
Regulatory headwinds have compounded the company’s challenges. Reports emerged in September 2025 that JPMorgan Chase was considering imposing fees on fintech companies for accessing its banking infrastructure, raising questions about the economics of Xero’s U.S. expansion. This development prompted RBC Capital to downgrade Xero from “Outperform” to “Sector Perform,” at the time, slashing the price target from A$230 to A$187 due to increased business complexity and uncertainty surrounding potential U.S. bank data access fees.
The broader technology sector sell-off in early February 2026 accelerated Xero’s decline, amid concerns over artificial intelligence advancements and their potential impact on traditional software companies. The tech-heavy Nasdaq index experienced parallel declines during this period, contributing to negative sentiment across the sector and leaving Xero particularly vulnerable given its elevated valuation multiples.
Xero’s dramatic fall from grace illustrates the market’s diminished tolerance for execution risk in a higher-rate environment where software multiples have compressed across the board. While the company retains strong positions in Australia and New Zealand with a loyal customer base and recurring revenue model, the path to validating its US$2.5 billion bet on Melio remains unclear, and markets appear unwilling to extend the benefit of the doubt until concrete evidence of successful integration and margin recovery emerges.
